Very recently it was found that in the brains of PD patients, the substantia nigra (the area subject to degeneration in PD), contains up to 3 times more non-specific cytosolic carnosinase, CNDP2[88], compared to controls. The gene discussed is CNDP2; the disease is Parkinson disease.